Revvity | الأصول



Assets تغيير تاريخ
Adcock Ingram Holdings ZAR 8.35B 25.86M 2024-06
Agilent USD 11.91B 68M 2025-01
Align Technology USD 6.21B 151.37M 2024-12
Bio Techne USD 2.67B 65.59M 2024-12
Bio-Rad Laboratories USD 9.36B 1.24B 2024-12
Bruker USD 5.81B 302.5M 2024-12
Celltrion KRW 20.31T 180.03B 2024-09
Charles River Laboratories USD 7.53B 475.5M 2024-12
Cspc Pharmaceutical CNY 47.9B 1.61B 2024-06
Danaher USD 77.54B 3.07B 2024-12
Dentsply International USD 5.75B 873M 2024-12
Dianthus Therapeutics USD 354.25M 14.71M 2024-09
Ecofibre AUD 71.25M 1.95M 2024-06
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Exact Sciences USD 5.93B 820.43M 2024-12
Hologic USD 8.73B 427.3M 2024-12
Illumina USD 6.3B 289M 2024-12
Intuitive Surgical USD 18.74B 999.8M 2024-12
IQVIA Holdings USD 26.9B 281M 2024-12
Kangmei Pharma CNY 14.19B 63.4M 2024-09
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 857.32M 78.66M 2024-06
Laboratory Of America USD 18.38B 233.5M 2024-12
Malin Corporation EUR 128.4M 11.8M 2024-06
Medical Developments International AUD 59.16M 31.9M 2024-06
Mettler Toledo International USD 3.24B 79.83M 2024-12
Myriad Genetics USD 1.03B 53.7M 2024-12
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Organigram Holdings CAD 479.21M 71.35M 2024-12
Patterson Companies USD 2.83B 13.02M 2025-01
Pharma Mar EUR 349.64M 16.52M 2024-12
Qiagen NV USD 5.69B 580.57M 2024-12
Quest Diagnostics USD 16.15B 58M 2024-12
Quidel USD 6.42B 377.5M 2024-12
Repligen USD 2.83B 31.28M 2024-09
Revvity USD 12.39B 377.26M 2024-12
Sartorius EUR 9.79B 148.6M 2024-09
Sino Biopharmaceutical CNY 66.7B 3.1B 2024-06
Thermo Fisher Scientific USD 97.32B 3.04B 2024-12
Tilray USD 4.19B 70.11M 2024-11
Waters USD 4.55B 42.18M 2024-12
Zz Pientze Pharmaceu 17.99B 940.45M 2024-09



Revvity الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.